scott hartz

Scott Hartz Chief Investment Officer Manulife Financial Corporation

Contact options for Scott Hartz

Scott Hartz is Chief Investment Officer for Manulife Financial Corporation. He oversees all U.S., Canadian and Asian general account investments, with total assets of approximately C$405 billion*. Mr. Hartz is also the Chief Investment Officer for John Hancock Life Insurance Company, a wholly owned subsidiary of Manulife. Manulife’s portfolio is composed of roughly 85% fixed income investments and 15% non-fixed income investments. A hallmark of the investment group which Mr. Hartz leads is its expertise in private asset classes. Within fixed income, the group underwrites and originates private placement debt and commercial and agricultural mortgages. Within non-fixed income, the group originates and manages commercial real estate, timber, agriculture, infrastructure, oil & gas, private equity, and mezzanine investments. Previously, Mr. Hartz oversaw all U.S. balance sheet investments for Manulife, a position he assumed in 2007. He was Senior Vice President and head of the Bond & Corporate Finance Group, overseeing all U.S. bond assets from 2004 to 2007. Before Manulife acquired John Hancock in 2004, he had been lead portfolio manager for John Hancock’s general account since 1998. Mr. Hartz, who began his career with John Hancock in 1983, joined the Portfolio Management Group in 1990 with responsibilities including managing the derivatives book. Mr. Hartz joined John Hancock in the retail life marketing support group as a rotation on the actuarial program. He joined the Investment Strategy Group in 1985 and was the asset/liability manager for the Retail Life Segments. He helped develop the Company’s use of financial futures for its hedging strategies, including managing and trading the futures’ book. Mr. Hartz graduated from Colby College with a B.A. in Physics and Economics. He is a Chartered Financial Analyst (CFA) and a Fellow of the Society of Actuaries (FSA). Mr. Hartz currently serves on the Board of Directors of Harvard Pilgrim Health Care.

*as at March 31, 2020, Canadian dollars